Elizabeth Anderson

Q: What is Elizabeth Anderson's success rate?

Elizabeth Anderson currently has a success rate of 90.96034898303866.

Q: What is the average return of Elizabeth Anderson's calls?

Their stock ratings have generated an average return of 9.380440874434813.

Evercore ISI Group | Healthcare

Elizabeth Anderson is an analyst from Evercore ISI Group specializing in the Healthcare sector. Ranked #1468 out of 4508 analysts, they have issued 43 stock ratings with a success rate of 90.96% and an average return of 9.38%.

Elizabeth Anderson has a well-established track record, with 43 ratings issued in the Healthcare sector. They have consistently delivered a success rate of 90.96% and an average return of 9.38%, underscoring their expertise and ability to identify winning opportunities for investors.

#1468

Out of 4508

Total Ratings

+90.96%

Success Rate

+9.38%

Average Return

Recent Ratings Analysis

FTRE

Buy

Jan 06, 2026

Target

$25.00

Current

$17.39

Performance

-0.86%

Elizabeth Anderson rated FTRE as Outperform on Jan 06, 2026, setting a price target of 25. Shares have remained stable near 17.39, leaving the 25 target still in play.

DOCS

Buy

Nov 07, 2025

Target

$70.00

Current

$43.79

Performance

-19.34%

On Nov 07, 2025, DOCS was given a Outperform rating by Elizabeth Anderson, with a target price of 70. Despite the Buy call, shares fell from 43.79 to 43.79, challenging the optimistic stance.

PRVA

Buy

Nov 07, 2025

Target

$30.00

Current

$23.04

Performance

-1.66%

PRVA received a Outperform rating from Elizabeth Anderson on Nov 07, 2025, aiming for 30. Price action was muted, as shares hovered around 23.04 despite the bullish outlook.

OMDA

Buy

Nov 07, 2025

Target

$28.00

Current

$15.41

Performance

-24.13%

On Nov 07, 2025, Elizabeth Anderson published a Outperform outlook on OMDA, with a target of 28. Market action contradicted the Buy thesis, as shares slipped to 15.41.

HSIC

Buy

Nov 05, 2025

Target

$90.00

Current

$77.64

Performance

7.82%

Elizabeth Anderson on Nov 05, 2025 assigned HSIC a Outperform rating, with a price target of 90. The Buy call aligned well with market performance, producing a gain of 7.82%.

CAH

Buy

Oct 31, 2025

Target

$220.00

Current

$201.11

Performance

5.42%

On Oct 31, 2025, Elizabeth Anderson reaffirmed CAH with a Outperform rating, targeting 220. The recommendation was supported by strong follow-through as the stock rose from 201.11 to 201.11.

TDOC

Hold

Oct 30, 2025

Target

$8.00

Current

$7.46

Performance

-14.65%

TDOC was rated In-Line by Elizabeth Anderson on Oct 30, 2025, with a price objective of 8. Investors who stayed cautious avoided some of the 14.65% decline.

ALGN

Buy

Oct 30, 2025

Target

$170.00

Current

$172.79

Performance

24.82%

On Oct 30, 2025, Elizabeth Anderson initiated coverage on ALGN with a Outperform rating and target of 170. The stock’s climb of 24.82% since the call highlights the foresight in the rating.

CVS

Buy

Oct 30, 2025

Target

$95.00

Current

$80.30

Performance

4.71%

Elizabeth Anderson issued a Outperform recommendation for CVS on Oct 30, 2025, price target set at 95. The target of 95 remains in play, though confirmation will depend on future moves.

XRAY

Hold

Oct 08, 2025

Target

$13.00

Current

$12.78

Performance

3.23%

On Oct 08, 2025, XRAY was evaluated by Elizabeth Anderson, who gave a In-Line rating and target of 13. Hold sentiment was validated by subdued trading with no breakout beyond 12.78.

DGX

Hold

Oct 08, 2025

Target

$190.00

Current

$174.44

Performance

-3.57%

Elizabeth Anderson rated DGX as In-Line on Oct 08, 2025, setting a price target of 190. The Hold stance appears justified, as shares hovered around 174.44 with a -3.57% move.

HCAT

Hold

Oct 08, 2025

Target

$3.00

Current

$2.47

Performance

-13.33%

On Oct 08, 2025, HCAT was given a In-Line rating by Elizabeth Anderson, with a target price of 3. The rating provided protection from downside risk as the stock fell to 2.47.

HNGE

Buy

Oct 08, 2025

Target

$65.00

Current

$47.92

Performance

-10.95%

HNGE received a Outperform rating from Elizabeth Anderson on Oct 08, 2025, aiming for 65. The rating hasn’t played out as hoped, with the stock trading 10.95% below expectations.

IQV

Buy

Oct 08, 2025

Target

$240.00

Current

$242.41

Performance

20.84%

On Oct 08, 2025, Elizabeth Anderson published a Outperform outlook on IQV, with a target of 240. Shares gained 20.84%, underscoring the accuracy of the bullish outlook toward 240.

LH

Buy

Oct 03, 2025

Target

$305.00

Current

$251.81

Performance

-9.07%

Elizabeth Anderson on Oct 03, 2025 assigned LH a Outperform rating, with a price target of 305. The call has struggled to gain traction, with shares losing 9.07%.

MCK

Buy

Sep 24, 2025

Target

$825.00

Current

$816.06

Performance

7.29%

On Sep 24, 2025, Elizabeth Anderson reaffirmed MCK with a Outperform rating, targeting 825. The recommendation was supported by strong follow-through as the stock rose from 816.06 to 816.06.

NVST

Buy

Jul 09, 2025

Target

$23.00

Current

$23.63

Performance

15.95%

NVST was rated Outperform by Elizabeth Anderson on Jul 09, 2025, with a price objective of 23. A bullish response from the market helped close the gap of -0.63 to the target.

AGL

Hold

Jul 09, 2025

Target

$3.00

Current

$0.99

Performance

-56.68%

On Jul 09, 2025, Elizabeth Anderson initiated coverage on AGL with a In-Line rating and target of 3. The rating matched the stock’s inability to hold above 0.9921.

WBA

Hold

Jan 13, 2025

Target

$12.00

Current

$11.98

Performance

0.67%

Elizabeth Anderson issued a In-Line recommendation for WBA on Jan 13, 2025, price target set at 12. The rating was appropriate for a consolidating market trading near 11.98.

WAY

Buy

Oct 08, 2024

Target

$32.00

Current

$34.50

Performance

25.91%

On Oct 08, 2024, WAY was evaluated by Elizabeth Anderson, who gave a Outperform rating and target of 32. This case illustrates how a timely bullish rating can translate into tangible gains of 25.91%.

Frequency Asked Questions

Who is Elizabeth Anderson?

Elizabeth Anderson is an analyst from Evercore ISI Group specializing in the Healthcare sector.

What is Elizabeth Anderson's success rate?

Elizabeth Anderson currently has a success rate of +90.96%.

How many ratings has Elizabeth Anderson issued?

Elizabeth Anderson has issued 43 stock ratings so far.

What is the average return of Elizabeth Anderson's calls?

Their stock ratings have generated an average return of +9.38%.

What is Elizabeth Anderson's ranking?

Elizabeth Anderson is ranked #1468 out of 4508 analysts.

What types of ratings does Elizabeth Anderson give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Elizabeth Anderson?

You can follow Elizabeth Anderson by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Elizabeth Anderson?

Their latest rating was a Buy on FTRE issued on 2026-01-06.